Formulation

Sep 28, 2017
By BioPharm International Editors
Nemera is now authorized to handle, assemble, sterilize, and store pharmaceutical drugs and medicinal products for autoinjector combination products at its facility in Neuenburg, Germany.
Sep 21, 2017
By BioPharm International Editors
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
Sep 15, 2017
BioPharm International
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Sep 15, 2017
BioPharm International
Consider automation early in the rollout of clinical translation and scale up of clinical-trial protocols.
Sep 15, 2017
BioPharm International
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Sep 15, 2017
The authors review methods for generating monoclonal antibodies for research and development.
Aug 28, 2017
By BioPharm International Editors
Genentech gets priority review for its application seeking a new indication for its anti-cancer drug, Gazyva (obinutuzumab), in treating follicular lymphoma.
Aug 25, 2017
By BioPharm International Editors
The generic pharmaceuticals firm has sold its Baddi, India formulations manufacturing facility following a recent fire at its joint-venture plant in Algeria.
Aug 16, 2017
By BioPharm International Editors
The US Patent and Trademark Office issued three new patents that extend protection for Alexion’s rare-disease drug, Soliris, for an additional 10 years.
Aug 07, 2017
By BioPharm International Editors
Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel.
native1_300x100
lorem ipsum